What does nucynta products — thereafter mean?

The aggregate projected amortization expense for Nucynta-related intangible assets for all fiscal years following the explicitly forecasted period. It represents the long-term tail of the asset's amortization schedule.

Collegium Pharmaceutical, Inc. COLL Nucynta Products — Thereafter

Other product segments

Jornay PM

$104.78M-44.4%

Symproic

$6.07M-54.5%

Belbuca

$0—

Similar metrics at other companies

LZBAnnual amortization expense, thereafter

$0—

PSXEstimated future amortization expense (less than)

$50M0.0%

MTCH2030 and thereafter

$21.98M-30.9%

PWPThereafter

$70.42M+40.6%

EVR

EVRGAmortization of Nuclear fuel

$16.7M+3.1%

JBIJanus North America — Amortization of intangibles

$11.7M+46.3%

Other financials

Income statement

See full

Revenue$193.5M+8.9%

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

See full

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

See full

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

See full

Market cap$1.15B+20.4%

Enterprise value$869.67M+2.5%

P/E15.4×-6.4×

P/S1.5×0.0×

Profitability

See full

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

Net margin9.4%+2.8pp

FCF margin41.4%+10.4pp

Returns & leverage

See full

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept coll:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s nucynta products — thereafter.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s nucynta products — thereafter?: Collegium Pharmaceutical, Inc. (COLL) reported nucynta products — thereafter of $0 in Q1 2026.
What does nucynta products — thereafter mean?: The aggregate projected amortization expense for Nucynta-related intangible assets for all fiscal years following the explicitly forecasted period. It represents the long-term tail of the asset's amortization schedule.